December 12, 2024

Innovation Prize 2025 of the German BioRegions – Application Deadline: February 14, 2025

Innovation Prize 2025 of the German BioRegions – Application Deadline: February 14, 2025
Go back

Innovators wanted. APPLY NOW!
WE SUPPORT YOUR INNOVATIVE INVENTION!

The work group of the BioRegions in Germany is the central network of regional initiatives promoting the economic use of modern biotechnologies in Germany. It annually awards the Innovation Prize of the BioRegions in Germany. This year, the work group again recognizes application-oriented ideas with strong implementation potential and showcases them at the German Biotech Days.

What is awarded?

  • The Innovation Prize honors innovative ideas that are patented or have been submitted for patenting.
  • We seek application-oriented ideas with strong implementation potential and high market opportunities.
  • Our aim is to support outstanding innovations that can significantly contribute to the economy and society.

Who can apply?

  • Scientists from universities and non-university institutions
  • Legal entities under public law, such as universities, universities of applied sciences, or patent exploitation agencies
  • Founders of companies that have not yet generated significant revenue and have not transferred substantial company shares to external investors

What do we offer?

  • Invitation for six finalists to the German Biotech Days on April 9 and 10, 2025, in Heidelberg
  • Presentation to an international audience, financiers, and the trade press
  • Three awards, each worth €2,000
  • An audience award worth €2,000

Apply now!

Application Deadline: February 14, 2025.

TO THE APPLICATION
Innopreis_2025_Flyer_EDownload

Our latest News

discover more
Contracts signed for Heidelberg-Mannheim hospital network

Contracts signed for Heidelberg-Mannheim hospital network

It’s now official: the alliance between the two university hospitals in Heidelberg and Mannheim can start as planned on January 1 and begin its work. Press release from the Baden-Württemberg Ministry of Science, Research, and the Arts. Full Text in German below. Verträge zum Klinikverbund Heidelberg-Mannheim unterzeichnet Nun ist es offiziell: Der Verbund zwischen den […]

read more
Cystic fibrosis research: AI-assisted evaluation of MRI images in chronic rhinosinusitis

Cystic fibrosis research: AI-assisted evaluation of MRI images in chronic rhinosinusitis

Persistent inflammation of the paranasal sinuses, chronic rhinosinusitis, is a common comorbidity in cystic fibrosis and significantly impairs quality of life. The working group led by Dr. Niclas Hagen, Institute for Medical Informatics at Heidelberg University’s Faculty of Medicine and Heidelberg University Hospital, is currently developing a method that uses AI to contribute to the […]

read more
New Research Group Leader at the Max Planck Institute for Medical Research

New Research Group Leader at the Max Planck Institute for Medical Research

In March 2026, Kevin Jahnke will establish a research group on ‘Biomembrane Engineering’ at the new Heilbronn site of the Max Planck Institute for Medical Research. Its focus will be on engineering synthetic lipid nano- and microstructures, with the aim of investigating the biophysics of both cells and lipid vesicles.  Connecting biophysical insights with biotechnological […]

read more

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp